» Articles » PMID: 34619091

Cellular Pathways Influenced by Protein Arginine Methylation: Implications for Cancer

Overview
Journal Mol Cell
Publisher Cell Press
Specialty Cell Biology
Date 2021 Oct 7
PMID 34619091
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

Arginine methylation is an influential post-translational modification occurring on histones, RNA binding proteins, and many other cellular proteins, affecting their function by altering their protein-protein and protein-nucleic acid interactions. Recently, a wealth of information has been gathered, implicating protein arginine methyltransferases (PRMTs), enzymes that deposit arginine methylation, in transcription, pre-mRNA splicing, DNA damage signaling, and immune signaling with major implications for cancer therapy, especially immunotherapy. This review summarizes this recent progress and the current state of PRMT inhibitors, some in clinical trials, as promising drug targets for cancer.

Citing Articles

PRMT3 and CARM1: Emerging Epigenetic Targets in Cancer.

Huang J, Qiao B, Yuan Y, Xie Y, Xia X, Li F J Cell Mol Med. 2025; 29(4):e70386.

PMID: 39964832 PMC: 11834966. DOI: 10.1111/jcmm.70386.


Biomedical effects of protein arginine methyltransferase inhibitors.

Cao M, Nguyen T, Song J, Zheng Y J Biol Chem. 2025; 301(3):108201.

PMID: 39826691 PMC: 11871472. DOI: 10.1016/j.jbc.2025.108201.


Arginine demethylation of Serine/Arginine-rich splicing factor 1 enhances miRNA enrichment in small extracellular vesicles derived from pancreatic ductal adenocarcinoma cells.

Bhandari K, Kong J, Ho W, Bourne P, Mooers B, Ding W FASEB J. 2025; 39(1):e70287.

PMID: 39760222 PMC: 11827091. DOI: 10.1096/fj.202401811RR.


PRMT1-mediated methylation regulates MLL2 stability and gene expression.

An D, Kim J, Moon B, Kim H, Nguyen H, Park S Nucleic Acids Res. 2024; 53(4).

PMID: 39698834 PMC: 11879031. DOI: 10.1093/nar/gkae1227.


Integration of transcriptional and epigenetic regulation of TFEB reveals its dual functional roles in Pan-cancer.

Luo J, Wang S, Fu J, Xu P, Shao N, Lu J NAR Cancer. 2024; 6(4):zcae043.

PMID: 39554489 PMC: 11567160. DOI: 10.1093/narcan/zcae043.


References
1.
Wei X, Yang J, Adair S, Ozturk H, Kuscu C, Lee K . Targeted CRISPR screening identifies PRMT5 as synthetic lethality combinatorial target with gemcitabine in pancreatic cancer cells. Proc Natl Acad Sci U S A. 2020; 117(45):28068-28079. PMC: 7668168. DOI: 10.1073/pnas.2009899117. View

2.
Tamiya H, Kim H, Klymenko O, Kim H, Feng Y, Zhang T . SHARPIN-mediated regulation of protein arginine methyltransferase 5 controls melanoma growth. J Clin Invest. 2017; 128(1):517-530. PMC: 5749505. DOI: 10.1172/JCI95410. View

3.
Jiang Y, Liu L, Yang S, Cao Y, Song X, Xiao J . Black carp PRMT6 inhibits TBK1-IRF3/7 signaling during the antiviral innate immune activation. Fish Shellfish Immunol. 2019; 93:108-115. DOI: 10.1016/j.fsi.2019.07.044. View

4.
Fong J, Pignata L, Goy P, Kawabata K, Chun-Wei Lee S, Koh C . Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation. Cancer Cell. 2019; 36(2):194-209.e9. PMC: 7194031. DOI: 10.1016/j.ccell.2019.07.003. View

5.
Clarke T, Sanchez-Bailon M, Chiang K, Reynolds J, Herrero-Ruiz J, Bandeiras T . PRMT5-Dependent Methylation of the TIP60 Coactivator RUVBL1 Is a Key Regulator of Homologous Recombination. Mol Cell. 2017; 65(5):900-916.e7. PMC: 5344794. DOI: 10.1016/j.molcel.2017.01.019. View